Vol. 4, Issue 6 (2015)

Author(s):
Kusa OM, Makarchuk OM

Abstract:
A clinical and clinical-laboratory examination of 130 women with viral and viral-bacterial infection verified at the stage of pre-gravid preparation was carried out. The control group consisted of 20 practically healthy women. We performed gynecological examination, reproductive and somatic history taking, bacterioscopic and bacteriological examination of vaginal contents. Infectious screening was carried out by identifying TORCH-group infections by enzyme immunoassay and polymerase chain reaction. Evaluation of parvovirus infection B-19 V was performed by identifying specific antibodies IgG and IgM using ELISA method. As a result, the study proved that patients in the study group - 41 women (31.53%) had no parvoviral symptoms of infection, 73 patients (82.02%) had characteristic symptoms at the planning stage of pregnancy long before the gestation. During ultrasound signs of uterine infection or threat of miscarriage in the first trimester - the antibodies to PV-B-19 (Ig G) were revealed in 68.46% of patients, 31.53% were seronegative, so they formed a group of high risk.